Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemia

Not available.

Saved in:

Bibliographic Details
Main Authors:	Roberta S. Azevedo, Wei-Ying Jen, Danielle Hammond, Fadi G. Haddad, Alexis Geppner, Ghayas C. Issa, Koji Sasaki, Jayastu Senapati, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-06-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12143
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet